University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 0C-17-5


A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors

Type: Treatment
Phase: Phase I/II
Status: Open to Accrual
Treatments: Biological Response Modifier, Chemotherapy: Systemic
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Heinz Josef Lenz, M.D.
Other Trial Staff:  Alicia Bogardus, Coordinator, Cristina De Leon, Coordinator, Deborah Fridman, Coordinator, Chi Nguyen, Coordinator, Maria Sharma, Coordinator, Leila Andres, Coordinator, Xiomara Menendez, Coordinator, Jessica Levano, Coordinator, Taison Tran, Coordinator, Jubilee Acap, Coordinator, Arthur Alvarez, D.M., Khatchik Karakozian, D.M., Sodech Kim, Coordinator, Atessa Kiani, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.